2023 年 37 巻 1 号 p. 13-18
In the era of widespread use of endovascular treatment (EVAR/TEVAR) for aortic aneurysms, the trend toward less invasive treatment has been accelerating. In Europe and the United States, vascular closure devices are covered by insurance, and percutaneous EVAR (pEVAR) accounts for the majority. Abbott’s Perclose PROGLIDE/PROSTYLE has been covered for EVAR/TEVAR in Japan since January 2021, and most EVARs with open surgical femoral access will likely be replaced with pEVAR in the near future. This manuscript presents an overview of pEVAR, focusing on tips for the procedure.